位置：成果数据库 > 期刊 > 期刊详情页
Research and development of highly potent antibody-drug conjugates for cancer therapy.
  • 时间：0
  • 相关项目：新基因MR1在人肿瘤中的功能和靶向治疗研究
同期刊论文项目
新基因MR1在人肿瘤中的功能和靶向治疗研究
期刊论文 23 会议论文 8 获奖 4 著作 3
同项目期刊论文
shRNA双表达载体pCSH1的构建及抗肿瘤活性研究.
靶向白血病特异性转录调节因子融合蛋白siRNA的研究进展.
F13 inhibits cell growth, migration & invasion vs induction of ERK- mediated RECK in HT-1080 cells.
Suppression of N-Ras by shRNA increases sensitivity of HepG2 cells to vincristine-induced growth inh
高效小型化抗肿瘤抗体药物的研究展望.
Efficient inhibition of B-cell lymphoma xenografts with a novel recombinant fusion protein
力达霉素-单抗Fab’片段不同连接偶联物的抗肿瘤作用比较研究.
Myofibrillogenesis regulator MR-1 as a potential target for cancer therapy.
Involvement of PI3K/Akt-GSK3β pathway in tetrandrine- induced G1 arrest and apoptosis.
Knockdown of Chk1 sensitizes HCT116 cells to LDM by abrogation of G2/M and induction of apoptosis.
小干扰RNA 介导的多靶点肿瘤治疗.
Dual knockdown of N-ras and epiregulin synergistically suppressed the growth of hepatoma HepG2 cells
MR-1 modulates proliferation and migration of hepatoma HepG2 cells through MLC2/FAK/Akt pathway.
靶向VEGF的shRNA与紫杉醇联合对前列腺癌DU145增效作用研究.
基因打靶技术在构建基因敲除或敲入细胞系中的应用.
G3BP：一个潜在的肿瘤治疗靶点.
小干扰RNA的靶向运送体系
Myofibrillogenesis regulator-1 promotes cell adhesion and migration in human hepatoma cells
基因打靶技术在构建人源体细胞基因敲除或敲入细胞系中的应用
G3BP：一个潜在的肿瘤治疗靶点
小干扰RNA介导的多靶点肿瘤治疗
靶向VEGF的shRNA与紫杉醇联合对人前列腺癌DU145的增效作用研究